After Myriad oral argument, Supreme Court set to decide patentability of isolated human DNA molecules *

USA - April 15 2013
Today, the Supreme Court of the United States heard oral argument in Association for Molecular Pathology v. Myriad Genetics, Inc. (No. 12-398) to…

Co-authors: Marc A. Hearron, Matthew I. Kreeger.

---

Australian Federal Court upholds Myriad’s gene patent *

Australia, USA - February 15 2013
While the question of patentability of isolated gene sequences awaits resolution at the U.S. Supreme Court, the Australian Federal Court today upheld…

Co-authors: Mary Prendergast.

---

Myriad finally gets its day in (the Supreme) Court *

USA - November 30 2012
The Supreme Court today granted certiorari in Assoc. for Molecular Pathology, et al. v. U.S. Patent and Trademark Office, et al. (Myriad), to address the issue of whether human genes are patentable.

Co-authors: Mary Prendergast.

---

Judges don’t budge in Myriad: Federal Circuit again finds isolated gene sequences are patent-eligible subject matter *

USA - August 16 2012
The Federal Circuit today issued its opinion in Assoc. for Molecular Pathology, et al. v. U.S. Patent and Trademark Office, et al. (“Myriad”), in which it re-affirmed its prior ruling, despite the Supreme Court’s instruction to revisit that ruling in light of its decision in Mayo Collaborative Services v. Prometheus Laboratories, Inc., ___U.S.___ (March 20, 2012) (“Prometheus”).

Co-authors: Mary Prendergast.

---

USPTO releases proposed first-inventor-to-file rules and examiner guidelines *

USA - July 27 2012
Implementation of the “first-to-file” provisions of the Leahy-Smith America Invents Act (AIA) took a step forward yesterday when the United States Patent and Trademark Office (USPTO) published proposed rules and proposed examination guidelines for the first-inventor-to-file provision of the AIA.

Co-authors: Colette R. Verkuil.

---